Cargando…
A case of BNT162b2 COVID‐19 vaccine‐associated fulminant myocarditis in a very elderly woman
Coronavirus disease 2019 (COVID‐19) vaccination is reportedly safe and effective. The histologic features of post‐COVID‐19 vaccination myocarditis are unknown. We present a case of a 77‐year‐old Japanese woman diagnosed with eosinophilic myocarditis using endomyocardial biopsy, 7 days after the seco...
Autores principales: | Otsuka, Kaishi, Matsuo, Takashi, Ishimatsu, Takashi, Fukae, Atsuki, Hamamoto, Takuro, Oku, Koji, Ito, Masahiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9445258/ https://www.ncbi.nlm.nih.gov/pubmed/36093466 http://dx.doi.org/10.1002/ccr3.6161 |
Ejemplares similares
-
Fulminant myocarditis and systemic hyperinflammation temporally associated with BNT162b2 mRNA COVID-19 vaccination in two patients
por: Abbate, Antonio, et al.
Publicado: (2021) -
Myocarditis after BNT162b2 Vaccination in Israeli Adolescents
por: Mevorach, Dror, et al.
Publicado: (2022) -
Acute myocarditis following administration of BNT162b2 vaccine
por: Habib, Mhd Baraa, et al.
Publicado: (2021) -
Myocarditis after BNT162b2 Vaccination in Israeli Adolescents
por: Witberg, Guy, et al.
Publicado: (2022) -
Fulminant myocarditis parvovirus B19 related in a young woman
por: Pesce, Rita, et al.
Publicado: (2021)